Illumina, the leading maker of DNA sequencing equipment, is partnering with Sanofi, AstraZeneca, and Johnson & Johnson to create a test for more mutations in dozens of genes that will be used first in clinical trials and, eventually, to help decide which patient should get which marketed drug. The tool is [...]